Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Investigate Which Altcoins Have Practical Use Cases by focusing on real applications, partnerships, and user adoption to guide choices.
27,754 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
U.S. stocks rise as inflation remains stubborn, oil prices jump, and growth slows. The Nasdaq Composite leads gains a...
Robinhood launches a controlled beta of its new Social feature, inviting a small group of users to follow traders, di...
Bitcoin built on recent gains as macro risk appetite improved and liquidity returned, setting the stage for a test of...
In a high-stakes Senate hearing, Treasury Secretary Scott Bessent denies a looming $14 billion windfall for Iran from...
Global oil inventories are near eight-year lows as tensions around Iran raise the risk of supply disruption. Prices h...
A pivotal moment in monetary policy unfolds as Warsh is confirmed to lead the Fed, with investors weighing how his st...
Arm is catching renewed investor attention as data-center demand for energy-efficient CPUs grows. Analysts say arm’s ...
A revived SpaceX IPO talk targets a multi‑trillion valuation, potentially lifting Elon Musk over $1 trillion in net w...
A memory-focused rally has vaulted a mid-cap equipment maker by about 90% in 2.5 months, shifting attention away from...
A consortium led by Barry Diller has proposed a $12.4 billion bid to take MGM Resorts private, a move that could resh...
NVIDIA CEO Jensen Huang contends AI will drive a hiring surge, not a wave of job losses. The comments come as investo...